Jeff Yass’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,800
Closed -$239K 13343
2022
Q3
$239K Buy
+4,800
New +$266K ﹤0.01% 10392
2021
Q3
Sell
-22,200
Closed -$1.16M 13336
2021
Q2
$1.16M Buy
22,200
+12,200
+122% +$586K ﹤0.01% 7358
2021
Q1
$441K Buy
10,000
+1,200
+14% +$50.4K ﹤0.01% 9768
2020
Q4
$307K Buy
8,800
+2,800
+47% +$99.4K ﹤0.01% 9203
2020
Q3
$219K Sell
6,000
-1,200
-17% -$44.6K ﹤0.01% 9310
2020
Q2
$270K Buy
+7,200
New +$288K ﹤0.01% 8536
2019
Q4
Sell
-8,100
Closed -$281K 10388
2019
Q3
$281K Buy
8,100
+700
+9% +$23.1K ﹤0.01% 8432
2019
Q2
$234K Sell
7,400
-700
-9% -$20.8K ﹤0.01% 8821
2019
Q1
$242K Sell
8,100
-300
-4% -$8.6K ﹤0.01% 7575
2018
Q4
$259K Sell
8,400
-26,600
-76% -$971K ﹤0.01% 7271
2018
Q3
$1.33M Buy
35,000
+17,700
+102% +$669K ﹤0.01% 4701
2018
Q2
$664K Buy
17,300
+5,400
+45% +$182K ﹤0.01% 6234
2018
Q1
$401K Buy
+11,900
New +$457K ﹤0.01% 7073
2017
Q1
Sell
-5,500
Closed -$287K 9682
2016
Q4
$287K Buy
5,500
+500
+10% +$24.1K ﹤0.01% 8058
2016
Q3
$241K Sell
5,000
-1,400
-22% -$70.8K ﹤0.01% 7287
2016
Q2
$355K Sell
6,400
-2,500
-28% -$138K ﹤0.01% 6688
2016
Q1
$475K Sell
8,900
-29,600
-77% -$1.46M ﹤0.01% 6494
2015
Q4
$1.98M Buy
38,500
+10,300
+37% +$512K ﹤0.01% 4051
2015
Q3
$1.27M Sell
28,200
-18,900
-40% -$893K ﹤0.01% 5180
2015
Q2
$2.18M Sell
47,100
-7,900
-14% -$346K ﹤0.01% 4530
2015
Q1
$2.36M Buy
+55,000
New +$2.1M ﹤0.01% 3999

Other funds holding PBH

Jeff Yass's PBH Position: Q2 2026 in Review

Jeff Yass reduced its Prestige Consumer Healthcare (PBH) stake by 85% in Q2 2026, selling an estimated $1.96M and leaving 6,876 shares worth $325K. The position accounts for ﹤0.01% of the portfolio, ranked #10866.

Jeff Yass first reported a position in PBH in Q2 2013 and has held it in 40 quarters since. The position peaked at $5.94M in Q1 2025. 318 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Jeff Yass held 6,876 shares of Prestige Consumer Healthcare worth $325K as of Q2 2026.
  • Jeff Yass sold 38,086 Prestige Consumer Healthcare shares in Q2 2026, an estimated $1.96M.
  • Prestige Consumer Healthcare made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #10866 holding.
  • Jeff Yass first reported a position in Prestige Consumer Healthcare in Q2 2013 and has held it in 40 quarters since.
  • Jeff Yass's Prestige Consumer Healthcare position peaked at $5.94M in Q1 2025.
  • 318 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.